Atrial Fibrillation

Detailed Overview

AFib replaces normal sinus rhythm with chaotic electrical impulses originating most commonly from the pulmonary vein ostia. The atria quiver at 300-600 bpm rather than contracting. The AV node blocks most of these impulses, resulting in an irregularly irregular ventricular response. The lack of organized atrial contraction leads to blood stasis, particularly in the left atrial appendage (LAA), massively increasing the risk of thromboembolic stroke. Management hinges on three pillars: rate control, rhythm control, and most importantly, stroke prevention via anticoagulation.

Epidemiology & Demographics

Affects over 33 million people worldwide. Prevalence sharply increases with age, affecting >10% of individuals over 80. More common in men and individuals of European descent.

Etiological Mechanism

Cardiac causes: hypertensive heart disease, coronary artery disease, valvular heart disease (especially mitral stenosis). Non-cardiac causes: hyperthyroidism, sleep apnea, acute alcohol intoxication ('Holiday Heart Syndrome'), and pulmonary embolism.

Primary Causes

Structural remodeling (fibrosis, dilation) and electrical remodeling (shortened refractory periods) of the atria create an anatomical substrate capable of sustaining multiple wandering re-entry wavelets.

• Hypertension: The most common modifiable risk factor, causing left atrial stretch and fibrosis.
• Obesity and Obstructive Sleep Apnea: Causes nocturnal hypoxemia and elevated right/left heart pressures, triggering AFib.
• Age: Degenerative changes in the cardiac conduction system increase susceptibility.

Trigger beats, typically premature atrial contractions firing from muscle sleeves extending into the pulmonary veins, hit an electrically vulnerable substrate (remodeled left atrium). Multiple micro-reentrant circuits form, wandering chaotically. This electrical chaos paralyzes the atrial muscle. Loss of the 'atrial kick' reduces cardiac output by up to 20%, triggering heart failure in borderline patients. Blood stagnates in the LAA, forming a fibrin-rich red clot that can embolize to the brain.

Characteristic Clinical Presentation

• Palpitations: A feeling of a racing, fluttering, or pounding heartbeat.
• Fatigue and Dyspnea: Shortness of breath on exertion due to reduced cardiac output and loss of atrial kick.
• Asymptomatic: Up to 30% of patients are completely unaware, with AFib discovered incidentally or during a stroke.

Physical Examination Signs

• Irregularly Irregular Pulse: No predictable pattern to the heart rate.
• Pulse Deficit: Apical heart rate auscultated with a stethoscope is higher than the palpable radial pulse.
• Absence of 'A' waves on jugular venous pressure (JVP) tracing.

• Ischemic Stroke: AFib causes strokes that are typically larger, more severe, and more fatal than atherosclerotic strokes.
• Tachycardia-Induced Cardiomyopathy: Prolonged rapid ventricular rates (>110 bpm for weeks) lead to LV dilation and severe heart failure.

Diagnostic Criteria & Guidelines

A 12-lead ECG demonstrating: 1) Absence of distinct repeating P waves; 2) Irregularly irregular R-R intervals (when AV conduction is intact); 3) Fine or coarse fibrillatory waves.

Differential Diagnosis

• Atrial Flutter (regular sawtooth pattern, though variable block can make it irregular)
• Multifocal Atrial Tachycardia (MAT - seen in COPD, 3 distinct P wave morphologies)
• Frequent Premature Atrial/Ventricular Contractions (PACs/PVCs)

Laboratory Tests & Biomarkers

• Thyroid Stimulating Hormone (TSH): Checked to rule out hyperthyroidism (suppressed TSH) as a reversible cause.
• Echocardiogram (TTE/TEE): Assesses Left Atrial size, LV ejection fraction, and TEE specifically looks for LAA thrombus.

Imaging Modalities & Findings

• 12-Lead ECG:
• Holter Monitor / Patch:

• Paroxysmal
  Terminates spontaneously or with intervention within 7 days.
• Persistent
  Continuous AFib lasting > 7 days, requiring electrical or pharmacologic cardioversion to stop.
• Permanent
  Patient and clinician jointly decide to stop further attempts to restore sinus rhythm.

Second-Line & Adjunctive Therapy

Rhythm Control (if symptomatic despite rate control or heart failure): Antiarrhythmics (Flecainide, Amiodarone, Sotalol) or Electrical Cardioversion (200 Joules synchronized shock). Catheter ablation (pulmonary vein isolation) is increasingly used first-line for symptomatic paroxysmal AFib.

Surgical & Procedural Management

Left Atrial Appendage Occlusion (LAAO) device (Watchman) for patients with high stroke risk who cannot tolerate long-term anticoagulation due to bleeding. Surgical Maze procedure performed concurrently during other open-heart surgeries.

Recommended Lifestyle Changes

• Absolute abstinence from alcohol, a potent trigger for AFib.
• Aggressive weight loss (targets >10% body weight) and screening/treatment for Sleep Apnea.
• Moderate aerobic exercise.

Patient Counseling & Advice

Educate extensively on the critical importance of DOAC compliance; missing even one or two doses removes stroke protection. Educate on the signs of stroke (FAST: Face drooping, Arm weakness, Speech difficulty, Time to call 911).

Follow-Up & Monitoring Schedule

Annual ECG, checking renal function (creatinine) to adjust DOAC dosing (e.g., Apixaban requires a dose reduction to 2.5 mg BID if 2 of the following: Age > 80, Weight < 60 kg, Creatinine > 1.5).

Preventive Strategies

Strict blood pressure control, treating sleep apnea with CPAP, and maintaining normal body weight.

AFib independently increases the risk of mortality twofold and the risk of stroke fivefold. However, with strict adherence to DOACs and rate control, life expectancy approaches that of the general population.